SHINE closes $80-million

SHINE closes $80-million Series C financing supported by Fidelity Management and Research Company LLC

SHINE Medical CEO Talks Europe Expansion, Future Phases of Company

In addition to creating a company that may soon supply two-thirds of the global demand for radioisotopes used in medical imaging, Wisconsin’s Greg Piefer is moving towards plans to create machinery that will produce clean energy and solve nuclear waste issues. At the...

New ways to make molybdenum-99

A crucial short-lived isotope is in short supply

One fear raised by those who oppose Britain’s leaving the European Union without a deal is that the import of radioactive isotopes for medicine would be at risk. These short-lived substances might, people wo

Shine Medical Technologies debuts therapeutics division

Medical isotopes maker Shine Medical Technologies last week created a division to make therapeutic products, saying it plans to first focus on a cancer treatment. The Janesville, Wis.-based company said its Shine Therapeutics business will begin with the development...